TG | Thyroglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SFTA3 | Surfactant associated 3 | | | | | | Group enriched |
TSHR | Thyroid stimulating hormone receptor | Cancer-related genes Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
SSX2B | Synovial sarcoma, X breakpoint 2B | Cancer-related genes Disease related genes
| | | | | Group enriched |
NKX2-1 | NK2 homeobox 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
SLC5A5 | Solute carrier family 5 (sodium/iodide cotransporter), member 5 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CALCB | Calcitonin-related polypeptide beta | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
TPO | Thyroid peroxidase | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
TBX22 | T-box 22 | Disease related genes Transcription factors
| | | | | Group enriched |
SLC26A4 | Solute carrier family 26 (anion exchanger), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
RAG2 | Recombination activating gene 2 | Disease related genes
| | | | | Tissue enriched |
DIO1 | Deiodinase, iodothyronine, type I | Enzymes Predicted membrane proteins
| | | | | Group enriched |
BMP8A | Bone morphogenetic protein 8a | Predicted secreted proteins
| | | | | Tissue enriched |
OTOS | Otospiralin | Predicted secreted proteins
| | | | | Tissue enriched |
CUX2 | Cut-like homeobox 2 | Plasma proteins Predicted membrane proteins Transcription factors
| | | | | Group enriched |
IYD | Iodotyrosine deiodinase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
SELV | Selenoprotein V | | | | | | Group enriched |
LIPI | Lipase, member I | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
SCUBE3 | Signal peptide, CUB domain, EGF-like 3 | Predicted secreted proteins
| | | | | Tissue enriched |
TMEM233 | Transmembrane protein 233 | Predicted membrane proteins
| | | | | Group enriched |
SLC26A7 | Solute carrier family 26 (anion exchanger), member 7 | Predicted membrane proteins
| | | | | Tissue enriched |
SYT14 | Synaptotagmin XIV | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
LECT1 | Leukocyte cell derived chemotaxin 1 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
ATF5 | Activating transcription factor 5 | Transcription factors
| | | | | Group enriched |
CALCA | Calcitonin-related polypeptide alpha | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CRYGN | Crystallin, gamma N | | | | | | Tissue enriched |
LIPG | Lipase, endothelial | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FAM155B | Family with sequence similarity 155, member B | Predicted membrane proteins
| | | | | Group enriched |
FOXE1 | Forkhead box E1 (thyroid transcription factor 2) | Disease related genes Transcription factors
| | | | | Tissue enriched |
HRK | Harakiri, BCL2 interacting protein (contains only BH3 domain) | Predicted membrane proteins
| | | | | Group enriched |
LRRC2 | Leucine rich repeat containing 2 | | | | | | Group enriched |
SERTM1 | Serine-rich and transmembrane domain containing 1 | Predicted membrane proteins
| | | | | Group enriched |
FAM132B | Family with sequence similarity 132, member B | Predicted secreted proteins
| | | | | Group enriched |
GALNT9 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) | Enzymes Predicted membrane proteins
| | | | | Group enriched |
PAX8 | Paired box 8 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enriched |
SLC4A5 | Solute carrier family 4 (sodium bicarbonate cotransporter), member 5 | Cancer-related genes Predicted membrane proteins
| | | | | Group enriched |
TCERG1L | Transcription elongation regulator 1-like | | | | | | Tissue enriched |
TMEM215 | Transmembrane protein 215 | Predicted membrane proteins
| | | | | Group enriched |
AC018867.2 | | Predicted membrane proteins
| | | | | Group enriched |
ANKRD18A | Ankyrin repeat domain 18A | | | | | | Group enriched |
CYP27B1 | Cytochrome P450, family 27, subfamily B, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Group enriched |
ERBB4 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
FCGBP | Fc fragment of IgG binding protein | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
IGFBPL1 | Insulin-like growth factor binding protein-like 1 | Predicted secreted proteins
| | | | | Tissue enriched |
KCNA2 | Potassium voltage-gated channel, shaker-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNJ16 | Potassium inwardly-rectifying channel, subfamily J, member 16 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KIAA1456 | KIAA1456 | | | | | | Tissue enriched |
KRT83 | Keratin 83 | Disease related genes
| | | | | Tissue enriched |
NAT16 | N-acetyltransferase 16 (GCN5-related, putative) | | | | | | Group enriched |
PDE8B | Phosphodiesterase 8B | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enriched |